Domiciliary VR Rehabilitation

Universitat Pompeu Fabra0 sites39 target enrollmentNovember 2011

ConditionsHemiparesis Functional Independence Movement Disorder Stroke

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Hemiparesis
Sponsor: Universitat Pompeu Fabra
Enrollment: 39
Primary Endpoint: Change in motor function for activities of daily living as measured by Chedoke Arm Hand Inventory clinical
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The purpose of this study is to determine whether domiciliary VR-based telerehabilitation is superior than domiciliary occupational therapy for inducing functional gains, enhancing corticospinal excitability, and cortical reorganization.

Registry

clinicaltrials.gov

Start Date

November 2011

End Date

July 2013

Last Updated

10 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Universitat Pompeu Fabra

Responsible Party

Principal Investigator

Paul Verschure

PhD

Universitat Pompeu Fabra

Eligibility Criteria

Inclusion Criteria

•Clinical diagnosis of Hemorrhagic or ischemic stroke
•Subject had the stroke more than 12 months ago.
•Subject presents mild-to-moderate upper-limbs hemiparesis (Proximal Medial Research Council Scale\>2) secondary to a first-ever stroke.
•Age between 45 and 85 years old.
•Subject has previous experience using the RGS system in the clinic.

Exclusion Criteria

•Subject presents a major cognitive impairment (Mini-Mental State Evaluation\> 22).

Outcomes

Primary Outcomes

Change in motor function for activities of daily living as measured by Chedoke Arm Hand Inventory clinical

Time Frame: At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.

Secondary Outcomes

Change in cognitive function as measured by the Mini-mental State Evaluation test(At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.)
Change in depression as measured by the Hamilton scale(At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.)
Change in motor function as measured by the upper extremity Fugl-Meyer Assessment(At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.)
Change in spasticity for the upper arms as measured by the Ashworth scale(At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.)
Change in shoulder pain as measured by the Visual Analog Assessment scale(At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.)
Change in motor function as measured by the Medical Research Council scale(At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.)
Change in Grip Force as measured by a grip dynamometer(At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.)